Latest news
Loading news…
Corlieve Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Paris, Ile-de-France, France Founded 2019 11-50 employees For Profit
Corlieve Therapeutics is a biotechnology company.
Corlieve Therapeutics was acquired by UniQure in 2021 for $55M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
0
2 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 31
- Patents granted
- 0
- Trademarks
- 2
- IT spend
- $449K
Company Info
- Founded
- 2019
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 13
- HQ
- Paris, Ile-de-France, France
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jun 23, 2021
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 0
- Trend (90d)
- -0.2
- Last leadership hire
- Sep 22, 2021
Key People at Corlieve Therapeutics
SVP CMC Manufacturing at Corlieve Therapeutics, a fully owned subsidiary of uniQure N.V.
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Corlieve Therapeutics
Loading news…
FAQs about Corlieve Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.